13F Pro Quality Score

73.9/100

Rank #176 of 2,879 stocksTOP 10%

View Financials peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

57.4/100

Profitability

96.9/100

Balance Sheet

39.1/100

Earnings Quality

81.9/100

Free Cash Flow

98.1/100

Institutional Flow

79.9/100

Revenue Scale

66.8/100

Dilution Risk

86.6/100

MET Stock Analysis & AI Quality Score

AI stock analysis and institutional research for METLIFE INC (MET), a Financials sector company. 13F Pro's AI-powered ranking engine scores MET at 73.9/100 on a 32-signal composite quality model, placing it at rank #176 of 2,879 stocks — the top 10% of the AI-ranked universe. MET scores in the top quartile across free cash flow (98.1), profitability (96.9), earnings quality (81.9). Areas of concern include balance sheet strength (39.1), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), METLIFE INC reports quarterly revenue of $19.1B, net income of $1.2B, an operating margin of 8.6%. Top institutional holders of MET by reported 13-F value include BlackRock,, DODGE & COX, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. MET trades on the NYSE exchange and files with the SEC under CIK 1099219. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MET daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for METLIFE INC directly from SEC EDGAR. METLIFE INC's 13F Pro composite quality score has ranged between 44 and 74 since 2021, currently 73.9 — an improving long-term trajectory across 28 quarterly and live scoring snapshots.

Fun facts about METLIFE INC

Quirks, history, and lore behind MET — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. financial services company · large-cap · listed on the NYSE · headquartered in New York City.
  • 2
    The Numbers
    One of the largest insurance companies in the world, with roughly $700 billion in total assets and operations in over 40 countries.
  • 3
    The History
    Founded in 1868 as a life insurance company, it spent most of its existence as a mutual company before converting to a publicly traded firm in 2000.
  • 4
    The Secret
    It was once so deeply embedded in American employee benefits that roughly one in five U.S. households had some kind of policy or plan through it.
  • 5
    The Lore
    For decades its Manhattan skyscraper was the tallest building in the world, and its ads featured a beloved cartoon beagle borrowed from the Peanuts comic strip.
  • 6
    The Giveaway
    Snoopy has been its spokesdog since the 1950s — and this company's name is literally stitched into the roof of a famous baseball stadium in Queens.
▶ Think you know your stocks? Play the Daily Ticker

What's Driving MET's Business? Latest 10-Q Breakdown

15/15 datapoints verified

AI-extracted from METLIFE INC's 10-Q filed 2026-05-07 — Q1 2026 (quarter ended March 31, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

MetLife reported Q1 2026 net income available to common shareholders of $1.1B, up 30% from $879M in Q1 2025, driven by $237M improvement in adjusted earnings and favorable tax rates.

Biggest Revenue Drivers

Total revenue: $19.1B+2.7% YoY

Premiums$12.1B+3.4% YoY

Growth in both voluntary and core products in Group Benefits; strong sales and persistency in Latin America

Net investment income$5.4B+9.6% YoY

Higher returns on private equity funds; higher yields on fixed income securities; higher average invested assets

Universal life and investment-type product policy fees$1.3B+9.3% YoY

Higher fee income from Japan's yen-denominated and foreign currency annuity products

Net investment gains (losses)$(670)M$(283)M unfavorable YoY

Foreign currency losses in current period vs. gains prior period; higher real estate impairments

Largest Expense Items

Policyholder benefits and claims and dividends$12.0B+0.3% YoY

Unfavorable morbidity in Group Benefits offset by favorable mortality results

Interest credited to policyholder account balances$1.7B+1.6% YoY

Higher average interest crediting rates on investment-type products in Asia

Other expenses, net of capitalization of DAC$2.9B+15.2% YoY

Higher commissions, direct and employee-related expenses; higher other segment expenses

Margins: Operating margins improved modestly despite revenue growth, driven by volume gains and favorable underwriting in Group Benefits and Asia. The company maintained disciplined expense management, though higher interest crediting rates in Asia offset some benefit from revenue growth.

Watch Items from the Filing

  • Asia segment showed strong adjusted earnings growth of $115M (+31% YoY) driven by market factors and volume growth, but higher interest crediting rates on investment products remain a headwind to margins.
  • Latin America adjusted premiums, fees and other revenues surged 25% YoY on reported basis, but only 11% on constant currency basis, indicating significant foreign exchange tailwind that may reverse if currencies weaken.
  • Net investment gains deteriorated $283M YoY due to foreign currency losses and higher real estate impairments ($136M in Q1 2026 vs. $1M in Q1 2025), signaling potential pressure from real estate portfolio.
  • Corporate & Other adjusted earnings available to common shareholders declined $48M YoY, including $33M headwind from reinsurance transactions closed in December 2025, reducing near-term earnings visibility.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Revenue

Q1 2026

$19.1B

Net Income

Q1 2026

$1.2B

Free Cash Flow

Q1 2026

$2.7B

Operating Margin

Q1 2026

8.6%

ROIC

Q1 2026

6.0%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+8.6% YoY
$77.08BFY 2025
FY21 $68.70BFY22 $68.77BFY24 $70.99BFY25 $77.08B

Net Income

-20.0% YoY
$3.38BFY 2025
FY21 $6.86BFY22 $2.35BFY24 $4.23BFY25 $3.38B

Operating Income

+2.4% YoY
$6.14BFY 2025
FY21 FY22 $5.98BFY24 $6.00BFY25 $6.14B

EPS (Diluted)

-20.7% YoY
$4.71FY 2025
FY21 $7.65FY22 $6.30FY24 $5.94FY25 $4.71

Total Assets

+10.0% YoY
$745.17BFY 2025
FY21 $759.71BFY22 $663.07BFY24 $677.46BFY25 $745.17B

Total Debt

-23.7% YoY
$355.0MFY 2025
FY21 $341.0MFY22 $175.0MFY24 $465.0MFY25 $355.0M

Op. Cash Flow

+17.1% YoY
$17.09BFY 2025
FY21 $12.35BFY22 $13.04BFY24 $14.60BFY25 $17.09B

AI Insight: MET Financial Trends

MetLife's revenue surged 28% in Q4 2025 to $23.8B while maintaining stable debt levels below $400M.

Revenue jumped from $17.4B in Q3 2025 to $23.8B in Q4 2025, a 37% quarterly increase.

Total debt declined from $465M in Q4 2024 to $355M in Q4 2025, down 24%.

Operating cash flow strengthened to $7.1B in Q4 2025 versus $4.6B in Q4 2024.

Net income dropped 36% from Q4 2024's $1.3B to $809M in Q4 2025 despite revenue surge.

Revenue volatility evident with Q4 2025 spike contrasting prior quarters' $17-18B range.

AI Insight: MET Ratio Trends

MetLife's operating margin improved from 6.5% in Q1 2024 to 8.0% in Q2 2025, but profitability declined in Q4 2025 with net margin falling to 3.4%.

Operating margin expanded from 6.5% in Q1 2024 to 8.0% in Q2 2025, showing gradual improvement.

ROIC strengthened from 14.6% in Q1 2024 to 23.4% in Q4 2025, indicating improving capital efficiency.

Debt-to-equity ratio remained extremely low at 0.01 throughout the period, maintaining strong balance sheet.

Net margin declined sharply from 5.2% in Q3 2025 to 3.4% in Q4 2025.

ROE fell from 18.5% in Q4 2024 to 11.4% in Q4 2025, reversing prior gains.

Get alerted when MET's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for METLIFE INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of MET

Put MET on your watchlist

Track score changes the day METLIFE INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is MET a good stock to buy?

13F Pro's AI-powered analysis of METLIFE INC (MET) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Financials sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for MET are available on the MET stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own MET?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling MET. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of METLIFE INC's investment landscape.